levofloxacin has been researched along with Benign Neoplasms in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Azéma, J; Dewelle, J; Guidetti, B; Kiss, R; Korolyov, A; Le Calve, B; Malet-Martino, M; Martino, R; Mijatovic, T; Vaysse, J | 1 |
| Azéma, J; Constant, P; Daffé, M; Guidetti, B; Kiss, R; Korolyov, A; Malet-Martino, M; Roques, C | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Gao, F; Wang, T; Xiao, J; Zhang, X | 1 |
| Hong, MY; Hsieh, CC; Ko, WC; Lee, CC; Lee, CH; Tang, HJ; Yang, CY | 1 |
| Alexander, S; Ammann, RA; Beauchemin, M; Cabral, S; Carlesse, F; Castagnola, E; Davis, BL; Dupuis, LL; Egan, G; Fisher, BT; Groll, AH; Haeusler, GM; Lehrnbecher, T; Phillips, B; Robinson, PD; Santolaya, M; Steinbach, WJ; Sung, L; van de Wetering, M; Wolf, J | 1 |
| Barnette, PE; Hersh, AL; Knackstedt, ED; Lemons, RS; Maese, L; Mehra, S; Olson, J; Pavia, AT; Stoddard, GJ; Thorell, EA | 1 |
| Fujita, S; Hata, A; Kaji, R; Katakami, N; Kitajima, N; Masuda, Y; Ose, T; Takashima, K; Takeshita, J; Tanaka, K | 1 |
| He, L; Weng, H; Yang, G; Zhao, S; Zhou, C | 1 |
| Nesher, L; Prince, RA; Rolston, KV; Shelburne, SA; Wang, W | 1 |
| Abe, M; Araoka, H; Baba, M; Kimura, M; Okada, C; Yoneyama, A | 1 |
| Petrosillo, N | 1 |
| Bompolaki, I; Bozionelou, V; Falagas, ME; Kalpadaki, C; Karageorgopoulos, DE; Koutsounaki, E; Mitsikostas, P; Samonis, G; Sgouros, J; Taktikou, V | 1 |
| Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T | 1 |
| Al-Khadimi, Z; Chow, WA; Doroshow, JH; Frankel, P; Lawrence, J; Leong, L; Lim, D; Longmate, J; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Synold, TW; Tetef, ML; Twardowski, P; Yen, Y | 1 |
| Allione, B; Amadori, S; Bucaneve, G; Buelli, M; Cantaffa, R; Cilloni, D; D'Antonio, D; Del Favero, A; Deliliers, GL; Dionisi, MS; Fabbiano, F; Foà, R; Lauria, F; Martinelli, G; Martino, P; Menichetti, F; Micozzi, A; Nosari, AM; Specchia, G; Zuffa, E | 1 |
| Billingham, L; Bower, M; Cullen, M; Fernando, I; Gaunt, C; Gollins, S; Hastings, M; Huddart, R; Rea, D; Simmonds, P; Stanley, A; Steven, N; Stuart, N | 1 |
| Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M | 1 |
| Billingham, LJ; Cullen, MH; Gaunt, CH; Steven, NM | 1 |
| Bodey, GP; Dholakia, N; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
| Dvorak, T; Ho, DH; LeBlanc, B; Rolston, KV; Streeter, H | 1 |
| Jacquet, A; Nepa, MC; Siegrist, HH | 1 |
| Ballone, E; Catamo, G; D'Antonio, D; Di Bonaventura, G; Piccolomini, R | 1 |
4 review(s) available for levofloxacin and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Quinolone hybrids and their anti-cancer activities: An overview.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Quinolones; Structure-Activity Relationship | 2019 |
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Child; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Neoplasms | 2020 |
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciprofloxacin; Decision Making; Drug Resistance; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Neoplasms; Neutropenia; Ofloxacin | 2006 |
6 trial(s) available for levofloxacin and Benign Neoplasms
| Article | Year |
|---|---|
Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China.
Topics: Administration, Oral; Anti-Bacterial Agents; Asian People; Blood Cell Count; Febrile Neutropenia; Humans; Levofloxacin; Neoplasms; Pilot Projects; Treatment Outcome | 2015 |
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome | 2004 |
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
Topics: Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Razoxane; Sarcoma; Sepsis; Treatment Outcome | 2004 |
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Bacterial Infections; Double-Blind Method; Female; Fever of Unknown Origin; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Risk | 2005 |
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Double-Blind Method; Female; Fever; Hospitalization; Humans; Leukocyte Count; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Risk; Systemic Inflammatory Response Syndrome | 2005 |
Rational selection of patients for antibacterial prophylaxis after chemotherapy.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Double-Blind Method; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Neoplasms; Ofloxacin; Patient Selection; Placebos; Risk Factors | 2007 |
13 other study(ies) available for levofloxacin and Benign Neoplasms
| Article | Year |
|---|---|
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Humans; Maximum Tolerated Dose; Mice; Neoplasms; Piperazine; Piperazines | 2009 |
Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacte
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Line, Tumor; Ciprofloxacin; Dimerization; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Ofloxacin | 2011 |
Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Community-Acquired Infections; Comorbidity; Enterobacteriaceae Infections; Female; Humans; Length of Stay; Levofloxacin; Male; Neoplasms; Retrospective Studies | 2019 |
Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer.
Topics: Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Female; Humans; Levofloxacin; Male; Neoplasms | 2021 |
[Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Neoplasms; Retrospective Studies | 2014 |
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Neoplasms; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Clavulanic Acids; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Minocycline; Neoplasms; Stenotrophomonas maltophilia; Ticarcillin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
[Experience accumulated in hospital setting with levofloxacin, in monotherapy and in association therapy].
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hospital Departments; Humans; Levofloxacin; Multicenter Studies as Topic; Neoplasms; Neutropenia; Ofloxacin; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2009 |
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Kidney Diseases; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Ofloxacin; Stereoisomerism | 1994 |
In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Neoplasms; Norfloxacin; Ofloxacin; Quinolones | 1997 |
Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology/oncology patients in Switzerland: a multicentre study.
Topics: Anti-Infective Agents; Bacteria; Hematologic Diseases; Hospital Units; Humans; Intensive Care Units; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Ofloxacin; Prospective Studies; Switzerland | 1999 |
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients.
Topics: Agar; Anti-Infective Agents; Culture Media; Diffusion; Drug Resistance, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Ofloxacin; Staphylococcus | 2002 |